NEW YORK (GenomeWeb) – The Cancer Research UK Manchester Institute announced today it has joined Cancer-ID, a European consortium to validate blood-based biomarkers for cancer. 

With a total budget of €14.5 million ($15.7 million), Cancer-ID is a newly created consortium funded by the Innovative Medicines Initiative. It currently has 33 members from 13 countries tasked with establishing standard protocols for and clinical validation of blood-based biomarkers, such as circulating tumor cells, cell-free tumor DNA, and microRNAs. 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Parabon NanoLabs is partnering with law enforcement to use genetic genealogy approaches to solve cold cases, Buzzfeed News reports.

A Columbia University-led team used emergency contact information from medical records to create family trees and estimate disease heritability.

In Science this week: ancient Southeast Asian genomes provide insight on human migration, and more.

NPR says a new report recommends that former research chimpanzees should be moved to retirement sanctuaries unless that move would shorten their lives.

Jun
19
Sponsored by
ACD

This webinar will provide evidence for the use of RNA in situ hybridization (RNA ISH) as a replacement for immunohistochemistry (IHC) in cancer research and diagnostic applications.